ZIMMER BIOMET HOLDINGS, INC. Other Comprehensive Income (Loss), Reclassification Adjustment on Derivatives Included in Net Income, Tax (Deprecated 2013-01-31)
ZIMMER BIOMET HOLDINGS, INC. (ZBH) reported Other Comprehensive Income (Loss), Reclassification Adjustment on Derivatives Included in Net Income, Tax (Deprecated 2013-01-31) of -$1.20 million for the 3-month period ending 2013-06-30, per its 10-Q filed 2013-08-07.
Discontinued › Expense Statement › Income Tax
us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentOnDerivativesIncludedInNetIncomeTax · last filed 2013-08-07
- ZIMMER BIOMET HOLDINGS, INC. other comprehensive income (loss), reclassification adjustment on derivatives included in net income, tax (deprecated 2013-01-31) for the quarter ending 2013-06-30 was -$1.20M, a 148.00% decline year-over-year.
- ZIMMER BIOMET HOLDINGS, INC. other comprehensive income (loss), reclassification adjustment on derivatives included in net income, tax (deprecated 2013-01-31) for the quarter ending 2013-03-31 was $1.60M, a 46.67% decline year-over-year.
- ZIMMER BIOMET HOLDINGS, INC. other comprehensive income (loss), reclassification adjustment on derivatives included in net income, tax (deprecated 2013-01-31) for the quarter ending 2012-06-30 was $2.50M.
- ZIMMER BIOMET HOLDINGS, INC. other comprehensive income (loss), reclassification adjustment on derivatives included in net income, tax (deprecated 2013-01-31) for the quarter ending 2012-03-31 was $3.00M.
- ZIMMER BIOMET HOLDINGS, INC. other comprehensive income (loss), reclassification adjustment on derivatives included in net income, tax (deprecated 2013-01-31) for fiscal 2012 was $8.90M, a 46.71% decline from fiscal 2011.
- ZIMMER BIOMET HOLDINGS, INC. other comprehensive income (loss), reclassification adjustment on derivatives included in net income, tax (deprecated 2013-01-31) for fiscal 2011 was $16.70M, a 288.37% increase from fiscal 2010.
- ZIMMER BIOMET HOLDINGS, INC. other comprehensive income (loss), reclassification adjustment on derivatives included in net income, tax (deprecated 2013-01-31) for fiscal 2010 was $4.30M.
| Period end | Other Comprehensive Income (Loss), Reclassification Adjustment on Derivatives Included in Net Income, Tax (Deprecated 2013-01-31) 3 month | Other Comprehensive Income (Loss), Reclassification Adjustment on Derivatives Included in Net Income, Tax (Deprecated 2013-01-31) 6 month | Other Comprehensive Income (Loss), Reclassification Adjustment on Derivatives Included in Net Income, Tax (Deprecated 2013-01-31) 12 month |
|---|---|---|---|
| 2013-06-30 | -$1.20M 10-Q · filed 2013-08-07 | $400.00K 10-Q · filed 2013-08-07 | |
| 2013-03-31 | $1.60M 10-Q · filed 2013-05-08 | ||
| 2012-12-31 | $8.90M 10-K · filed 2013-02-27 | ||
| 2012-06-30 | $2.50M 10-Q · filed 2013-08-07 | $5.50M 10-Q · filed 2013-08-07 | |
| 2012-03-31 | $3.00M 10-Q · filed 2013-05-08 | ||
| 2011-12-31 | $16.70M 10-K · filed 2013-02-27 | ||
| 2010-12-31 | $4.30M 10-K · filed 2013-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B |